JF
NPCE icon

Jump Financial’s Neuropace NPCE Stock Holding History

Jump Financial’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Sell
16,887
-8,813
-34% -$132K ﹤0.01% 1617
2025
Q4 		$397K Buy
+25,700
New +$344K ﹤0.01% 1418
2025
Q3 		– Sell
-40,474
Closed -$451K – 2064
2025
Q2 		$451K Buy
40,474
+27,965
+224% +$350K 0.01% 1267
2025
Q1 		$154K Buy
+12,509
New +$157K ﹤0.01% 1467
2024
Q3 		– Sell
-11,431
Closed -$86.4K – 1969
2024
Q2 		$86.4K Sell
11,431
-14,107
-55% -$142K ﹤0.01% 1656
2024
Q1 		$337K Buy
+25,538
New +$364K 0.01% 1386

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jump Financial's NPCE Position: Q1 2026 in Review

Jump Financial reduced its Neuropace (NPCE) stake by 34% in Q1 2026, selling an estimated $132K and leaving 16,887 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Jump Financial first reported a position in NPCE in Q1 2024 and has held it in 6 quarters since. The position peaked at $451K in Q2 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Jump Financial held 16,887 shares of Neuropace worth $222K as of Q1 2026.
  • Jump Financial sold 8,813 Neuropace shares in Q1 2026, an estimated $132K.
  • Neuropace made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1617 holding.
  • Jump Financial first reported a position in Neuropace in Q1 2024 and has held it in 6 quarters since.
  • Jump Financial's Neuropace position peaked at $451K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.